The European Society for Biomaterials has recently published a report on biomaterials research translation in Europe.

The European Society for Biomaterials (ESB) is a non-profit organisation which aims to tackle unmet clinical needs by means of advanced materials for medical devices and regenerative medicine.

ESB has recently published a report on the biomaterials research translation in Europe. This report was commissioned in 2014 by the ESB Council in collaboration with the Presidents of the national societies of biomaterials across Europe.

The report maps out the current research, innovation, consultancy and state-of- the-art facilities across Europe. It also identifies potential sources of funding and investments, research trends, success stories and gaps to be filled.

Furthermore, the report highlights the added value of the networking, the increasing number of projects focusing on biomaterials for regenerative medicine, and the numerous projects that have reached the stage of clinical validation and commercial exploitation.

Photo galleries are not available for content from the previous KTN website: we apologise for this.

In the report editorial ESB President, Prof Matteo Santin said:

“We all agreed that the main scope of the study should be to present the ESB community in all its richness, potential and cohesiveness to the various stakeholders. We wanted to make our presence felt as a resource for all those involved in medical innovation. We wanted to present ourselves as a community of technopreneurs; innovative minds able to pioneer new technology, experts able to understand the needs of industry and determined to assist companies in the resolution of problems, responsible professionals capable of informing and influencing policy makers and regulatory bodies.”

You can download the report here.

 

If you would like to discuss opportunities for innovation in biomaterials you can contact Gabriela Juarez Martinez, Knowledge Transfer Manager (Pharma/MedTech)

Share this article